US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Stage

0.3754

0.0000

Volume:- -

Turnover:- -

Market Cap:10.85M

PE:-0.11

High:0.3754

Open:0.3754

Low:0.3754

Close:0.3754

52wk High:9.50

52wk Low:0.2700

Shares:28.91M

Float Shares:20.31M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.05

Dividend Rate:13.32%

EPS(TTM):-3.3321

EPS(LYR):-3.1264

ROE:-44.60%

ROA:-3.54%

PB:0.07

PE(LYR):-0.12

Loading ...

Overview Company News Filings

Artivion’s New Chord-X Mitral Valve Study Sets Stage for Long-Term Value

Ionis Ends Early-Stage Hero Study in Down Syndrome Alzheimer’s Risk: What Investors Should Know

Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating

AstraZeneca’s AZD5462 Heart Failure Trial Reaches Key Mid-Stage Milestone

Axsome Therapeutics: Strengthened Sunosi Exclusivity and Robust Late‑Stage Pipeline Underpin Buy Rating

Krystal Biotech: Strong Vyjuvek Momentum, Robust Balance Sheet, and Late-Stage Pipeline Upside Support Buy Rating

Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026

AE Fuels Advances Stage 3 CSIRO Testwork for High-Purity Manganese Sulphate

Eurocell Completes £5 Million Share Buyback, Sets Stage for Further Capital Returns

Balanced View on Solventum: Differentiated Healthcare IT AI Offsets Early-Stage Turnaround Risk, Supporting a Hold Rating

European Software Stocks Stage Cautious Recovery

Press Release: Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company

Novartis Says Vanrafia Late-Stage Data Support Slowing of Kidney Function Decline in IgA Nephropathy Patients

MT Newswires Live

NervGen Pharma CFO to Retire as Company Advances Late-Stage SCI Program

Early-Stage Venture Funds Have to Be Big to Compete, VC Says -- Market Talk

BridgeBio: De-Risked Achondroplasia Program and Expanding Late-Stage Rare-Disease Portfolio Underpin Buy Rating and Blockbuster Growth Outlook

Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market

Tietoevry Calls 2026 AGM and Proposes Two-Stage Dividend of EUR 0.88 per Share

American Airlines Staff To Stage Protest, Demand 'Accountability' After Historic No-Confidence Vote On CEO Robert Isom

Alpha HPA Says Solvent Extraction Tanks Delivered to Site for Queensland Project Stage Two Construction; Shares Fall 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SSI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","market":"US","secType":"STK","nameCN":"Stage","latestPrice":0.3754,"timestamp":1588968000000,"preClose":0.3754,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":20307519,"shares":28911336,"eps":-3.332056,"marketStatus":"Halted","change":0,"latestTime":"05-08 16:00:00 EDT","open":0.3754,"high":0.3754,"low":0.3754,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.332056,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":998884800000,"exchange":"NYSE","adjPreClose":0.3754,"dividendRate":0.133191,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SSI\",,,,,undefined,":{"symbol":"SSI","floatShares":20307519,"roa":"-3.54%","roe":"-44.60%","lyrEps":-3.1264,"shares":28911336,"dividePrice":0.05,"high":0.3754,"amplitude":0,"preClose":0.3754,"low":0.3754,"week52Low":0.27,"pbRate":"0.07","week52High":9.5,"institutionHeld":0.5253,"latestPrice":0.3754,"eps":-3.332056,"divideRate":0.133191,"volume":0,"delay":0,"ttmEps":-3.332056,"open":0.3754,"prevYearClose":8.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-21","symbol":"SSI","fiscalQuarterEnding":"2019/10","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1574312400000,"reportTimeType":"pre","actualEps":-0.15},{"date":"2019-08-22","symbol":"SSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2019/07","expectedEps":null,"defaultRemindTime":1566460800000,"name":null,"time":"Pre-Market","dateTimestamp":1566446400000,"actualEps":-0.6},{"market":"US","date":"2019-05-23","symbol":"SSI","fiscalQuarterEnding":"2019/04","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1558584000000,"reportTimeType":"pre","actualEps":-1.67},{"market":"US","date":"2019-03-07","symbol":"SSI","fiscalQuarterEnding":"2019/01","expectedEps":0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"pre","actualEps":0.25},{"market":"US","date":"2018-12-03","symbol":"SSI","amount":0.05,"name":"Stage Stores Inc","currency":"USD","type":"dividend","dateTimestamp":1543813200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SSI\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-24","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-08-25","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2017-11-27","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"},{"executeDate":"2018-03-05","recordDate":null,"paymentDate":null,"value":0.05,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SSI\",market:\"US\",delay:true,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SSI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613086295","title":"Artivion’s New Chord-X Mitral Valve Study Sets Stage for Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2613086295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613086295?lang=en_us&edition=fundamental","pubTime":"2026-02-21 00:34","pubTimestamp":1771605256,"startTime":"0","endTime":"0","summary":"Artivion Inc. ($AORT) announced an update on their ongoing clinical study. This new Artivion Inc. registry, titled “Mitral Valve Repair With the Ch...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artivions-new-chord-x-mitral-valve-study-sets-stage-for-long-term-value?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artivions-new-chord-x-mitral-valve-study-sets-stage-for-long-term-value?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0031619046.USD","IE00B19Z4B17.USD","SSI","BK4082","IE00B66KJ199.SGD","AORT","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"2613703295","title":"Ionis Ends Early-Stage Hero Study in Down Syndrome Alzheimer’s Risk: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2613703295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613703295?lang=en_us&edition=fundamental","pubTime":"2026-02-21 00:31","pubTimestamp":1771605109,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals Inc. ($IONS) announced an update on their ongoing clinical study. The Hero study, officially titled “A Phase 1b Study to Asse...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ionis-ends-early-stage-hero-study-in-down-syndrome-alzheimers-risk-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ionis-ends-early-stage-hero-study-in-down-syndrome-alzheimers-risk-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","BK4211","ISBC"],"gpt_icon":0},{"id":"2612127405","title":"Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2612127405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612127405?lang=en_us&edition=fundamental","pubTime":"2026-02-19 17:25","pubTimestamp":1771493138,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Ritu Baral maintained a Buy rating on Inventiva on February 17 and set a price target of €10.00. Ritu Baral has given his Buy rati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/inventiva-strong-balance-sheet-and-late-stage-mash-candidate-lanifibranor-drive-compelling-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/inventiva-strong-balance-sheet-and-late-stage-mash-candidate-lanifibranor-drive-compelling-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2612447944","title":"AstraZeneca’s AZD5462 Heart Failure Trial Reaches Key Mid-Stage Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2612447944","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612447944?lang=en_us&edition=fundamental","pubTime":"2026-02-19 00:30","pubTimestamp":1771432213,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has completed a mid-stage study called “A Phase IIb Two-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazenecas-azd5462-heart-failure-trial-reaches-key-mid-stage-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazenecas-azd5462-heart-failure-trial-reaches-key-mid-stage-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2462157665.USD","LU0320765992.SGD","LU0289739699.SGD","LU0109394709.USD","SSI","BK4585","LU0889565916.HKD","LU1829250122.USD","LU2236285917.USD","AZN","LU2456880835.USD","BK4588","BK4007","BK4568","LU2417539215.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2612410506","title":"Axsome Therapeutics: Strengthened Sunosi Exclusivity and Robust Late‑Stage Pipeline Underpin Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2612410506","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612410506?lang=en_us&edition=fundamental","pubTime":"2026-02-18 19:38","pubTimestamp":1771414721,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju has reiterated their bullish stance on AXSM stock, giving a Buy rating on February 2. Ram Selvaraju has given...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-strengthened-sunosi-exclusivity-and-robust-late‑stage-pipeline-underpin-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/axsome-therapeutics-strengthened-sunosi-exclusivity-and-robust-late‑stage-pipeline-underpin-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","AXSM"],"gpt_icon":0},{"id":"2612749955","title":"Krystal Biotech: Strong Vyjuvek Momentum, Robust Balance Sheet, and Late-Stage Pipeline Upside Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2612749955","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612749955?lang=en_us&edition=fundamental","pubTime":"2026-02-18 07:16","pubTimestamp":1771370198,"startTime":"0","endTime":"0","summary":"In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Krystal Biotech, with a price target of $306.00. Ritu Baral has giv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/krystal-biotech-strong-vyjuvek-momentum-robust-balance-sheet-and-late-stage-pipeline-upside-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/krystal-biotech-strong-vyjuvek-momentum-robust-balance-sheet-and-late-stage-pipeline-upside-support-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","SSI"],"gpt_icon":0},{"id":"2612659234","title":"Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612659234","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612659234?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:46","pubTimestamp":1771343160,"startTime":"0","endTime":"0","summary":"Rallybio reports strong Phase 1 results for RLYB116, showing full immune pathway control with good safety and Phase 2 plans ahead.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/17/biotech-lab.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/17/biotech-lab.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/02/50655870/rallybio-shares-successful-early-stage-results-for-rare-disease-drug-new-trial-set-for-late-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50655870/rallybio-shares-successful-early-stage-results-for-rare-disease-drug-new-trial-set-for-late-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4539","SMA","RLYB","BK4217","SSI","BK4139"],"gpt_icon":0},{"id":"2612465355","title":"AE Fuels Advances Stage 3 CSIRO Testwork for High-Purity Manganese Sulphate","url":"https://stock-news.laohu8.com/highlight/detail?id=2612465355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612465355?lang=en_us&edition=fundamental","pubTime":"2026-02-17 23:39","pubTimestamp":1771342783,"startTime":"0","endTime":"0","summary":"AE Fuels Corporation ( ($TSE:AEF) ) has shared an announcement. AE Fuels has launched a Stage 3 testwork program with Australia’s national science ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ae-fuels-advances-stage-3-csiro-testwork-for-high-purity-manganese-sulphate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ae-fuels-advances-stage-3-csiro-testwork-for-high-purity-manganese-sulphate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2612280437","title":"Eurocell Completes £5 Million Share Buyback, Sets Stage for Further Capital Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2612280437","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612280437?lang=en_us&edition=fundamental","pubTime":"2026-02-17 15:16","pubTimestamp":1771312568,"startTime":"0","endTime":"0","summary":"Eurocell ( ($GB:ECEL) ) just unveiled an update. Eurocell has completed a £5 million share buyback programme, repurchasing a total of 3,478,173 ord...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eurocell-completes-5-million-share-buyback-sets-stage-for-further-capital-returns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eurocell-completes-5-million-share-buyback-sets-stage-for-further-capital-returns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2612448108","title":"Balanced View on Solventum: Differentiated Healthcare IT AI Offsets Early-Stage Turnaround Risk, Supporting a Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448108","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448108?lang=en_us&edition=fundamental","pubTime":"2026-02-17 01:05","pubTimestamp":1771261521,"startTime":"0","endTime":"0","summary":"Analyst Travis Steed of Bank of America Securities maintained a Hold rating on Solventum Corporation, retaining the price target of $85.00. Travis ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balanced-view-on-solventum-differentiated-healthcare-it-ai-offsets-early-stage-turnaround-risk-supporting-a-hold-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balanced-view-on-solventum-differentiated-healthcare-it-ai-offsets-early-stage-turnaround-risk-supporting-a-hold-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV","SOLV","SSI","VGT"],"gpt_icon":0},{"id":"2611880150","title":"European Software Stocks Stage Cautious Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2611880150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611880150?lang=en_us&edition=fundamental","pubTime":"2026-02-13 21:37","pubTimestamp":1770989820,"startTime":"0","endTime":"0","summary":"Shares in European software companies were among the sharpest risers in the Europe-wide Stoxx 600 index Friday, as traders looked for a bottom to selling sparked by fears over artificial-intelligence.RELX, Experian and Capgemini all gained in afternoon European trade. London-listed RELX led the pack, climbing 7% to trade at 21.86 pounds.The companies were among the first stocks hit by a global software selloff earlier this month sparked by concerns that AI agents would eat into software companies' markets.Traders judging the selling as overly-severe stepped in to push a basket of European software stocks up 1.5%. However, the stocks still have a long way to go to recover to their pre-selloff levels.RELX, for example, trades over 15% below its Feb. 2 close, the day before markets jumped on a new AI plug-in from Anthropic that promised to help legal teams automate some of their work. Data provider RELX provides a range of AI tools for the legal sector.However, the company's unique access","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","CGEMY","VGT","AI","EXPGY","BK4588","BK4134","BK4551","SSI","BK4585","BK4023","BK4543","RELX","BK4528","BK4587"],"gpt_icon":0},{"id":"2611156454","title":"Press Release: Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2611156454","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611156454?lang=en_us&edition=fundamental","pubTime":"2026-02-13 19:30","pubTimestamp":1770982200,"startTime":"0","endTime":"0","summary":"-- Upfront Proceeds of USD 200 Million, with Potential for up to USD 200 Million in Additional Proceeds --. -- Expected to Fund Completion of Phase 3 ENSURE Trials in Relapsing Multiple Sclerosis, Initiation of Phase 3 Trial in Primary Progressive Multiple Sclerosis, and Transition into a Commercial Organization --. -- Simona Skerjanec, Former SVP, Global Head of Neuroscience and Rare Diseases at Roche, Elevated to Interim Chairperson of the Board of Directors --. -- Thor Nagel, Principal at BVF Partners L.P., Joins Board of Directors --. -- Simona Skerjanec and Dr. Daniel Vitt to Lead Search for CEO with Commercial Background --. The proceeds of this financing are expected to support Immunic's strategic transition from a research and development (R&D)-focused company into a fully integrated commercial entity. In the coming months, the company will prioritize:. With these pivotal programs underway, Immunic is positioning itself to become a leading innovator in next--generation oral the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU0795875086.SGD","LU0158827948.USD","BK4127","LU0225283273.USD","LU0267386448.USD","LU1244550221.USD","LU1244550494.USD","LU1363072403.SGD","LU1548497426.USD","LU0557290698.USD","LU1668664300.SGD","IE00BZ1G4Q59.USD","LU1720051017.SGD","IE00BKVL7J92.USD","LU0528227936.USD","USD","LU1732800096.USD","LU1791710582.SGD","IMUX","LU1989772840.SGD","LU0006306889.USD","SSI","LU2023251221.USD","LU0882574139.USD","BK4581","LU1720051108.HKD","LU0314104364.USD","LU2347655156.SGD","BK4534","LU0795875169.SGD","LU2089283258.USD","LU2111349929.HKD","LU0234570918.USD","LU1162221912.USD","BK4585","LU0106831901.USD","LU0158827781.USD","LU0098860793.USD","BK4139","LU1989772923.USD","LU2028103732.USD","LU0912757837.SGD","LU1074936037.SGD","LU0971096721.USD","LU1791710400.SGD","BK4504","AAQC","BK4588","LU0320765646.SGD"],"gpt_icon":0},{"id":"2611533581","title":"Novartis Says Vanrafia Late-Stage Data Support Slowing of Kidney Function Decline in IgA Nephropathy Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2611533581","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611533581?lang=en_us&edition=fundamental","pubTime":"2026-02-13 18:28","pubTimestamp":1770978531,"startTime":"0","endTime":"0","summary":"Novartis  said Friday that final results from a phase III study supported a slowing decline in kidney function in adults with IgA nephropathy, a progressive autoimmune kidney disease, who were treated with Vanrafia, or atrasentan.Data showed \"clinically meaningful results\" with Vanrafia, compared with placebo in estimated glomerular filtration rate change from baseline at the end of study treatment at week 132, the company said.Novartis said safety was consistent with prior findings.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0208291251.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0211331839.USD","BK4585","IE00BJT1NW94.SGD","BK4578","IE0009355771.USD","SSI","NVS","IE00BFTCPJ56.SGD","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4532","LU0320765489.SGD","IE0002141913.USD","BK4007"],"gpt_icon":0},{"id":"2611034529","title":"NervGen Pharma CFO to Retire as Company Advances Late-Stage SCI Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2611034529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611034529?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:53","pubTimestamp":1770933180,"startTime":"0","endTime":"0","summary":"The latest announcement is out from NervGen Pharma ( ($TSE:NGEN) ). NervGen Pharma, a clinical-stage biopharmaceutical company developing neurorepa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nervgen-pharma-cfo-to-retire-as-company-advances-late-stage-sci-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nervgen-pharma-cfo-to-retire-as-company-advances-late-stage-sci-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2611908588","title":"Early-Stage Venture Funds Have to Be Big to Compete, VC Says -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2611908588","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611908588?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:24","pubTimestamp":1770931440,"startTime":"0","endTime":"0","summary":"1624 ET - Venture firms that invest in seed-stage startups need much more capital to compete in the current market, said Benjamin Sun, partner and co-chief investment officer at Primary Venture Partners. Primary, for example, raised $625 million across two new funds, almost 50% more than in its prior fundraising in 2023. \"We need to make sure we can show up and compete not only with small seed funds but with the big multistage and megafunds, as well,\" Sun said. Venture firms put more than $20 billion into seed-stage startups in the U.S. last year, compared to about $5 billion a decade ago, according to the PitchBook-NVCA Venture Monitor report. Sun said valuations and deal sizes, as well as the size of ultimate exits have grown. \"Seed is just a lot bigger now and more competitive and founders have more choice,\" Sun said. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VC","V03.SI","SG9999008742.SGD","BK6062","SG9999000475.SGD","LU0757428866.USD","SG9999004220.SGD","BK4124","LU1815336091.USD","SG9999004360.SGD","SG9999006266.SGD","SG9999014484.SGD","BK6515","SG9999001846.SGD","IE00BZ199S13.USD","SG9999001135.SGD","SG9999014492.USD","SSI"],"gpt_icon":0},{"id":"2611971043","title":"BridgeBio: De-Risked Achondroplasia Program and Expanding Late-Stage Rare-Disease Portfolio Underpin Buy Rating and Blockbuster Growth Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2611971043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611971043?lang=en_us&edition=fundamental","pubTime":"2026-02-13 03:15","pubTimestamp":1770923719,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on BridgeBio Pharma today and set a price target of $100.00. Andrew Tsai has given his Buy ra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bridgebio-de-risked-achondroplasia-program-and-expanding-late-stage-rare-disease-portfolio-underpin-buy-rating-and-blockbuster-growth-outlook-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bridgebio-de-risked-achondroplasia-program-and-expanding-late-stage-rare-disease-portfolio-underpin-buy-rating-and-blockbuster-growth-outlook-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2611377975","title":"Sun Pharma’s GL0034 Diabetes Trial: Early-Stage Data Catalyst in a Crowded Metabolic Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2611377975","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611377975?lang=en_us&edition=fundamental","pubTime":"2026-02-13 00:31","pubTimestamp":1770913902,"startTime":"0","endTime":"0","summary":"Sun Pharmaceutical Industries Limited ($IN:SUNPHARMA) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Ltd. is ru...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sun-pharmas-gl0034-diabetes-trial-early-stage-data-catalyst-in-a-crowded-metabolic-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sun-pharmas-gl0034-diabetes-trial-early-stage-data-catalyst-in-a-crowded-metabolic-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI"],"gpt_icon":0},{"id":"2610924295","title":"Tietoevry Calls 2026 AGM and Proposes Two-Stage Dividend of EUR 0.88 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2610924295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610924295?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:55","pubTimestamp":1770904543,"startTime":"0","endTime":"0","summary":"TietoEVRY ( ($GB:0KG0) ) has shared an update. Tietoevry has convened its shareholders to the Annual General Meeting, scheduled for 24 March 2026 a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tietoevry-calls-2026-agm-and-proposes-two-stage-dividend-of-eur-0-88-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tietoevry-calls-2026-agm-and-proposes-two-stage-dividend-of-eur-0-88-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGM","BK4195","BK4229","SSI"],"gpt_icon":0},{"id":"2610249229","title":"American Airlines Staff To Stage Protest, Demand 'Accountability' After Historic No-Confidence Vote On CEO Robert Isom","url":"https://stock-news.laohu8.com/highlight/detail?id=2610249229","media":"Benzinga","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610249229?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:41","pubTimestamp":1770903660,"startTime":"0","endTime":"0","summary":"The Association of Professional Flight Attendants (APFA), representing over 28,000 flight attendants of the American Airlines Group (NYSE: AAL), will hold a protest on Thursday, calling for \"accountability and leadership change.\"","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/12/Phoenix--Az---December-7--2019-Photo-Of-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/12/Phoenix--Az---December-7--2019-Photo-Of-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/travel/26/02/50574435/american-airlines-staff-to-stage-protest-demand-accountability-after-historic-no-confidence-vote-on-ceo-robert-isom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/travel/26/02/50574435/american-airlines-staff-to-stage-protest-demand-accountability-after-historic-no-confidence-vote-on-ceo-robert-isom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4547","BK4008","SSI","BK4585","BK4588","BK4500","AAL"],"gpt_icon":0},{"id":"2610957659","title":"Alpha HPA Says Solvent Extraction Tanks Delivered to Site for Queensland Project Stage Two Construction; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610957659","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610957659?lang=en_us&edition=fundamental","pubTime":"2026-02-12 09:45","pubTimestamp":1770860757,"startTime":"0","endTime":"0","summary":"Alpha HPA  said solvent extraction tanks were delivered to the site for the construction of stage two of the HPA First project in Queensland, according to a Thursday statement.The solvent extraction circuit is a key part of the design to produce ultra-high-purity aluminum materials.Its shares fell 3% in recent trading on Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["A4N.AU","BK7017","SSI"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}